[print friendly]

methylphenidate [extended release] (CONCERTA, DAYTRANA [TRANSDERMAL], METADATE CD, METADATE ER, METHYLIN ER, RITALIN LA)

• methylphenidate [extended release] (CONCERTA, DAYTRANA [TRANSDERMAL], METADATE CD, METADATE ER, METHYLIN ER, RITALIN LA); methylphenidate [immediate release] (METHYLIN, RITALIN); methylphenidate [sustained release] (RITALIN-SR)

• Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder [hide all summaries]
  To correctly establish the diagnosis of ADHD requires the use not only of medical but also of special psychological, educational, and social resources. Many children diagnosed with ADHD actually have problems that are primarily caused or worsened by inadequate teachers, unsuitable educational settings, or by problems with their parents. Similarly, many adults diagnosed with ADHD may have interpersonal problems that need to be dealt with by psychotherapy.

• American Heart Association Recommends Screening for Heart Disease in Children Getting Drugs for ADHD [hide all summaries]
  (June 2008)
  The American Heart Association (AHA) has just recommended specific screening for heart problems for children and adolescents before they get stimulant drugs for treating attention deficit hyperactivity disease (ADHD). The recommendations include a thorough history, a physical exam focussing on the heart and, according to the American Heart Association, that it is reasonable to obtain an electrocardiogram. The article lists the components of an adequate history and physical exam to look for the presence of pre-existing heart disease in children.
• Pharmacists Ordered to Distribute Medication Guides About Serious Heart, Psychiatric Problems Linked to Attention Deficit Drugs [hide all summaries]
  (August 2007)
  Patients currently taking drugs approved for the treatment of ADHD who experience any of the cardiac or psychiatric side effects mentioned in this article are advised to seek medical attention immediately.
• FDA Issues Stronger Warnings for ADHD Stimulants; Warnings Don’t Go Far Enough [hide all summaries]
  (November 2006)
  If you are considering treatment with a stimulant ADHD drug for yourself or your child, become familiar with the new warnings for these drugs that are presented in this article. The new warnings do not tell patients that the drugs can also cause sudden death in those using the medication properly, not just in those abusing the drugs.

• Drug Recall for methylphenidate [extended release] (CONCERTA) reported in May 20, 2009 FDA Enforcement Report
• Drug Recall for methylphenidate [extended release] (CONCERTA) reported in May 20, 2009 FDA Enforcement Report
• Drug Recall for methylphenidate [extended release] (CONCERTA) reported in May 20, 2009 FDA Enforcement Report
• Drug Recall for methylphenidate [extended release] (CONCERTA) reported in May 20, 2009 FDA Enforcement Report
• Drug Recall for methylphenidate [extended release] (DAYTRANA [TRANSDERMAL]) reported in May 20, 2009 FDA Enforcement Report
• Drug Recall for methylphenidate [extended release] (DAYTRANA [TRANSDERMAL]) reported in May 20, 2009 FDA Enforcement Report
• Drug Recall for methylphenidate [extended release] (DAYTRANA [TRANSDERMAL]) reported in May 20, 2009 FDA Enforcement Report
• Drug Recall for methylphenidate [extended release] (DAYTRANA [TRANSDERMAL]) reported in May 20, 2009 FDA Enforcement Report
• Drug Recall for methylphenidate [extended release] (METADATE CD) reported in May 20, 2009 FDA Enforcement Report
• Drug Recall for methylphenidate [extended release] (METADATE CD) reported in May 20, 2009 FDA Enforcement Report
• Drug Recall for methylphenidate [extended release] (METADATE CD) reported in May 20, 2009 FDA Enforcement Report
• Drug Recall for methylphenidate [extended release] (METADATE CD) reported in May 20, 2009 FDA Enforcement Report
• Drug Recall for methylphenidate [extended release] (METADATE ER) reported in May 20, 2009 FDA Enforcement Report
• Drug Recall for methylphenidate [extended release] (METADATE ER) reported in May 20, 2009 FDA Enforcement Report
• Drug Recall for methylphenidate [extended release] (METADATE ER) reported in May 20, 2009 FDA Enforcement Report
• Drug Recall for methylphenidate [extended release] (METADATE ER) reported in May 20, 2009 FDA Enforcement Report
• Drug Recall for methylphenidate [extended release] (METHYLIN ER) reported in May 20, 2009 FDA Enforcement Report
• Drug Recall for methylphenidate [extended release] (METHYLIN ER) reported in May 20, 2009 FDA Enforcement Report
• Drug Recall for methylphenidate [extended release] (METHYLIN ER) reported in May 20, 2009 FDA Enforcement Report
• Drug Recall for methylphenidate [extended release] (METHYLIN ER) reported in May 20, 2009 FDA Enforcement Report
• Drug Recall for methylphenidate [extended release] (RITALIN LA) reported in May 20, 2009 FDA Enforcement Report
• Drug Recall for methylphenidate [extended release] (RITALIN LA) reported in May 20, 2009 FDA Enforcement Report
• Drug Recall for methylphenidate [extended release] (RITALIN LA) reported in May 20, 2009 FDA Enforcement Report
• Drug Recall for methylphenidate [extended release] (RITALIN LA) reported in May 20, 2009 FDA Enforcement Report

SHOW secondary search results for methylphenidate [extended release] (CONCERTA, DAYTRANA [TRANSDERMAL], METADATE CD, METADATE ER, METHYLIN ER, RITALIN LA)